Industry: Psychological testing Region: Japan Transaction price: US$1 million Transaction method: Equity financing
❖Company Profile
Registered capital: 58 million yen
Date of establishment: January 2015
❖Providing services
Studies have shown that the production of reactive oxygen species in the human body is closely related to the development of mental illnesses caused by psychological stress. When the amount of reactive oxygen species in the body increases, a substance called "oxidative metabolite of bilirubin" (Biopyrrin) in the urine also increases accordingly.
Biopyrrin has been reported to increase significantly under psychological stress or mental illness. In May 2021, researchers at Shimane University School of Medicine found that in patients with psychosis (ARMS, At-RiskMental State), that is, before the onset of mental illness, Biopyrrin levels began to increase, so it is recommended to use it. to understand and assess the risk of pre-onset mental illness.
Through the Biopyrrin inspection, the stress people are subjected to can be accurately quantified. Therefore, the detection of Biopyrrin, which was studied in Japan, is currently attracting worldwide attention as a psychological stress test method that can quantify the causes of mental illness.
Stress can lead to mental illness, as well as various physical and mental illnesses such as high blood pressure. Although stress can be improved by adjusting your daily life (avoiding overwork; getting enough sleep, etc.), when you are under stress that has adverse effects on your body and mind, it is sometimes difficult to self-awareness, and it is difficult to use your own strength to improve your life and achieve behavior. Change.
The test for Biopyrrin in urine allows people to easily collect urine as a sample and is therefore also suitable for simple and frequent tests and measurements.
The ARMS risk marker "Biopyrrin" testing service package we provide (non-medical use, cannot be used for preventive/medical diagnostic purposes. Testing kits for medical use are currently available in Japan) can be collected by users themselves and mailed to cooperative partners The testing agency will send the results to the mobile app for display about 2 working days after the testing. Thousands of service packs have been sold in the Tohoku region of Japan.
❖Cooperation needs
We hope to launch our ARMS risk marker "Biopyrrin" testing service package to the world. We hope that there will be companies willing to help us enter the Chinese market, and we also welcome doctors or companies interested in our technology to contact us.